Mycologia
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parshikov, I. A.
Right arrow Articles by Sutherland, J. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Parshikov, I. A.
Right arrow Articles by Sutherland, J. B.
Agricola
Right arrow Articles by Parshikov, I. A.
Right arrow Articles by Sutherland, J. B.
Mycologia 94(1), 2002, pp. 1-5
© 2002 by The Mycological Society of America

Formation of conjugates from ciprofloxacin and norfloxacin in cultures of Trichoderma viride


Igor A. Parshikov 1
Joanna D. Moody
James P. Freeman
Jackson O. Lay Jr.
Anna J. Williams
Thomas M. Heinze
John B. Sutherland 2

     National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas 72079-9502

    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 

The formation of conjugates from two antibacterial fluoroquinolone drugs, ciprofloxacin and norfloxacin, was observed in cultures of Trichoderma viride that had been grown in sucrose-peptone broth and extracted 16 d after dosing with the drugs. Both conjugates were purified by high-performance liquid chromatography and found to be optically active. They were identified by mass and proton nuclear magnetic resonance spectra as 4-hydroxy-3-oxo-4-vinylcyclopent-1-enyl ciprofloxacin and 4-hydroxy-3-oxo-4-vinylcyclopent-1-enyl norfloxacin. The transformation of veterinary fluoroquinolones in the presence of fungi may have ecological significance.

Key words: biotransformation, fluoroquinolones


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
At present, limited information is available about the ability of fungi to transform fluoroquinolones, such as the widely used antibacterial agents ciprofloxacin (Fig. 1A ) and norfloxacin (Fig. 1B ). Several fungi transform the fluoroquinolones enrofloxacin, danofloxacin, and sarafloxacin to various metabolites (Martens et al 1996Citation , Chen et al 1997Citation , Wetzstein et al 1997Citation , Parshikov et al 2000, 2001aCitation ). Mucor ramannianus transforms ciprofloxacin to N-acetylciprofloxacin (Parshikov et al 1999Citation ). Gloeophyllum striatum and other wood-decaying basidiomycetes convert ciprofloxacin to at least 16 metabolites, including CO2 (Wetzstein et al 1999Citation ). Pestalotiopsis guepini transforms both ciprofloxacin and norfloxacin to N-acetyl, desethylene-N-acetyl, and N-formyl metabolites as well as to metabolites in which an amino group has replaced the piperazine ring (Parshikov et al 2001bCitation ).



View larger version (18K):
[in this window]
[in a new window]
 
 FIG. 1. Structures of compounds used for dosing cultures. A. Ciprofloxacin. B. Norfloxacin. C. Piperidine.

 
Recently, the formation of two new products in cultures of Trichoderma viride was noted after dosing with ciprofloxacin and norfloxacin. The strain had been isolated during the screening of soil fungi for the ability to metabolize fluoroquinolones. Both ciprofloxacin and norfloxacin appeared to be conjugated with an unstable secondary metabolite, which had been previously reported in other Trichoderma spp. (Mukhopadhyay et al 1996Citation ).


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Strain T-58, isolated from a fruiting body of Trametes versicolor collected in a forest in Jefferson County, Arkansas, was identified as Trichoderma viride by Dr. S. N. Lekomtseva, Department of Mycology and Algology, Moscow State University, Moscow, Russia. Triplicate experimental cultures in flasks containing sucrose-peptone broth (Parshikov et al 1999Citation ) were incubated at 28 C with rotary shaking at 180 rpm. After 2 d, the cultures were dosed with 300 µM ciprofloxacin or 313 µM norfloxacin (Parshikov et al 2001bCitation ); in one experiment, 300 µM piperidine hydrochloride (Aldrich Chemical Co.) was substituted. The dosed cultures, control cultures, and noninoculated controls were incubated with shaking for another 16 d.

After harvesting, cultures were extracted with ethyl acetate (Parshikov et al 1999Citation ) and the residues were dissolved in methanol: acetonitrile: acetic acid (10:10:2) for analysis. Compounds were purified by collecting the peaks separated by high-performance liquid chromatography (HPLC), using the gradient described previously (Parshikov et al 2001aCitation ), and the relative concentrations were estimated from the peak areas at 280 nm. Circular dichroism spectra were obtained in methanol with a Jasco model 500A spectropolarimeter.

Direct exposure probe (DEP) mass spectrometry (MS) experiments were performed as previously described (Parshikov et al 1999Citation ), using the single quadrupole (Q1) and product-ion modes. The ion-source pressure for chemical ionization was 5.0–5.5 Torr, uncorrected. Product ions were generated with a collision-cell pressure of 0.5 mTorr of argon and a collision energy of 100 eV. Electrospray ionization (ESI) MS experiments (Parshikov et al 1999Citation ) were performed by either flow injection or LC/ESI MS. For flow injection, the mobile phase was 50% methanol with 0.1% trifluoroacetic acid. For LC/ESI MS, a procedure described previously (Parshikov et al 2000Citation ) was used except that the percent solvent B was 50% from 0 to 3 min and then was increased to 90% in a 15-min linear gradient. LC/ESI MS/MS experiments (Parshikov et al 1999Citation ) were performed with a collision energy of 25–50 eV.

1H nuclear magnetic resonance (NMR) spectroscopy was performed at 500 MHz (Parshikov et al 1999Citation ) with the compounds dissolved in deuterated chloroform. 13C NMR spectroscopy was performed on one compound at 125.77 MHz.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Ciprofloxacin – HPLC analysis of the ethyl acetate extracts from cultures of T. viride dosed with ciprofloxacin showed residual ciprofloxacin eluting at 11.1 min and an apparent metabolite at 21.7 min. Other peaks were found but were also detected in the controls. After 16 d, as shown by the peak areas at 280 nm, 31% of the ciprofloxacin had been transformed to the product and 69% remained unchanged. The ciprofloxacin product had a UV absorption spectrum with {lambda}max = 291 and 332 nm. The circular dichroism spectrum had a positive Cotton effect at 295 nm, indicating that the compound was optically active.

The DEP/NICI mass spectrum of the ciprofloxacin product (Table I ) consisted of a molecular anion [M-.] at m/z 453 and an oxygen adduct [M + O2]-. at m/z 485. The product-ion (NICI MS/MS) mass spectrum (Table I ) for the ion at m/z 453 had significant fragment ions at m/z 412 [M - 41]-, 368 [M - 85]-, and 246 [M - 207]-. The LC/ESI MS/MS mass spectrum (not shown) had an intense fragment ion at m/z 436 [MH–H2O]+ and several smaller ions.


View this table:
[in this window]
[in a new window]
 
TABLE I. Mass spectral data for ciprofloxacin, norfloxacin, and the conjugates found in cultures of T. viride

 
The 1H NMR spectrum for the ciprofloxacin product is shown in Fig. 2 ; proton resonances that corresponded to those found in the spectrum of ciprofloxacin were assigned accordingly (Table II ). Five additional resonances (Ha–He) appeared to be part of an additional 123-Dalton moiety that had been detected by mass spectrometry (Fig. 3A ). The resonances at 5.22, 5.44, and 5.88 (Hb–d) had multiplicities and coupling constants consistent with a vinyl group. In addition, there were two singlets at 2.87 and 5.13 ppm (Ha and He) that integrated as two and one, respectively. Irradiation of each resonance resulted in a nuclear Overhauser effect (NOE) at the piperazine ß resonance; irradiation of the resonance at 2.87 ppm (Ha) produced an NOE at 5.88 pm (Hb), even though these protons were not coupled to one another. A proton-decoupled 13C NMR spectrum (not shown) was acquired from the ciprofloxacin conjugate and showed the same resonances (within 1.44 ppm) as those reported for a 4-hydroxy-3-oxo-4-vinylcyclopent-1-enyl moiety (Mukhopadhyay et al 1996Citation ), as well as those consistent with the carbons of the molecule. The NMR data show that the protons are arranged on a five-membered carbon ring. Based on the MS and NMR results, the ciprofloxacin product (Fig. 3A ) was identified as a conjugate, 1-cyclopropyl-6-fluoro-7-[4-(4-hydroxy-3-oxo-4-vinylcyclopent-1-enyl)piperazinyl]-4-oxohydroquinoline-3-carboxylic acid (= 4-hydroxy-3-oxo-4-vinylcyclopent-1-enyl ciprofloxacin).



View larger version (16K):
[in this window]
[in a new window]
 
 FIG. 2. 1H NMR spectrum, obtained in CDCl3 at 500 MHz, of the ciprofloxacin metabolite (4-hydroxy-3-oxo-4-vinylcyclopent-1-enyl ciprofloxacin) produced by T. viride

 

View this table:
[in this window]
[in a new window]
 
TABLE II. 1H NMR spectral data for ciprofloxacin, norfloxacin, and the conjugates found in cultures of T. viridea

 


View larger version (17K):
[in this window]
[in a new window]
 
 FIG. 3. Structures of metabolites produced by T. viride from fluoroquinolones. A. 4-Hydroxy-3-oxo-4-vinylcyclopent-1-enyl ciprofloxacin. B. 4-Hydroxy-3-oxo-4-vinylcyclopent-1-enyl norfloxacin. The carbon atoms are numbered as shown in the NMR data and the asymmetric carbon atom is shown by an asterisk

 
Norfloxacin – HPLC analysis of the ethyl acetate extracts from cultures of T. viride dosed with norfloxacin showed residual norfloxacin eluting at 10.9 min and an apparent metabolite at 21.5 min. Other peaks were found but were also detected in the controls. After 16 d, as shown by the peak areas at 280 nm, 42% of the norfloxacin had been transformed into the product and 58% remained unchanged. The norfloxacin product had a UV absorption spectrum with {lambda}max = 286, 321 and 330 nm. The circular dichroism spectrum had a positive Cotton effect at 292 nm, indicating that the compound was optically active.

The DEP/NICI mass spectrum of the norfloxacin product (Table I ) consisted of the molecular anion [M-.] at m/z 441 and an oxygen adduct [M + O2]-. at m/z 473. The product-ion (NICI MS/MS) mass spectrum (Table I ) for the ion at m/z 441 had significant fragment ions at m/z 412 [M - 29]- and 368 [M - 73]-. The LC/ESI MS/MS mass spectrum (not shown) had an intense fragment ion at m/z 424 [MH–H2O]+ and several smaller ions.

The 1H NMR spectrum of the norfloxacin product (Table II ) was similar to that of norfloxacin for the H2, H5, H8, ethyl (Hf–g), and piperazine (H{alpha}–ß) resonances. It also showed five additional resonances (Ha–e) with chemical shifts (Fig. 3B ) that were the same as those of the substituted cyclopentenyl ring in the ciprofloxacin conjugate. Based on the MS and NMR results, the norfloxacin product was identified as a conjugate, 1-ethyl-6-fluoro-7-[4-(4-hydroxy-3-oxo-4-vinylcyclopent-1-enyl)piperazinyl]-4-oxohydroquinoline-3-carboxylic acid (= 4-hydroxy-3-oxo-4-vinylcyclopent-1-enyl norfloxacin).

Piperidine – To determine whether similar conjugates could be produced from other secondary amines, cultures of T. viride were grown with 300 µM piperidine (Fig. 1C ). Metabolites were extracted and analyzed directly by LC/ESI MS; one peak was found that was consistent with a conjugate similar to those seen for ciprofloxacin and norfloxacin. A positive-ion ESI mass spectrum with collision-induced dissociation showed ions at m/z 208 (3) [MH]+, 190 (29) [MH-H2O]+, 162 (100) [MH-H2O-C2H4]+, and 134 (9) [MH-H2O-2C2H4]+. This spectrum is consistent with the structure of 4-hydroxy-3-oxo-4-vinylcyclopent-1-enyl piperidine.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Sulfate, formyl, and acetyl conjugates of ciprofloxacin (Zeiler et al 1987Citation , Parshikov et al 1999, 2001bCitation ) and formyl, acetyl, and glucuronide conjugates of norfloxacin (Pauliukonis et al 1984Citation , Parshikov et al 2001bCitation ) have previously been detected as products of various biological reactions. The compounds produced from these two fluoroquinolones in cultures of T. viride, in contrast, were optically active 4-hydroxy-3-oxo-4-vinylcyclopent-1-enyl conjugates.

The structures of the fluoroquinolone conjugates are reminiscent of 5-hydroxy-3-methoxy-5-vinyl-2-cyclopenten-1-one, derived from cultures of T. album (Strunz et al 1977Citation ), and 3-dimethylamino-5-hydroxy-5-vinyl-2-cyclopenten-1-one, derived from cultures of T. koningii (Mukhopadhyay et al 1996Citation ). When we dosed cultures of T. viride with piperidine, a secondary amine similar to the piperazine moiety of ciprofloxacin and norfloxacin, we found evidence of its conjugation with the same unstable fungal metabolite found by Mukhopadhyay et al. This showed that other secondary amines may also react with the metabolite produced by Trichoderma spp. We suspect that the conjugation is a chemical process, because an enzymatic process would not be likely to work with all secondary amines.

Although the antibacterial activities of the conjugates produced by T. viride have not yet been investigated due to the minuscule amounts that have been available so far, those ciprofloxacin metabolites that have been tested have generally had significantly lower antibacterial activities than the parent drug (Zeiler et al 1987Citation ). Since species of Trichoderma and similar fungi are widespread on straw and other cellulose-rich debris in the environment (Cooke and Rayner 1984Citation ), the conjugation of fluoroquinolone residues with fungal metabolites may be ecologically important where these drugs are used for treatment of livestock and poultry.

3-Dimethylamino-5-hydroxy-5-vinyl-2-cyclopenten-1-one has no apparent antibacterial or antifungal activity (Mukhopadhyay et al 1996Citation ). However, the addition of the unstable Trichoderma spp. metabolite to other compounds may potentially be a useful reaction for the modification of secondary amines that are being investigated as antimicrobial agents, antidepressants, or anticancer drugs.


    ACKNOWLEDGMENTS
 
We thank C. E. Cerniglia and E. B. Hansen, Jr., for their useful suggestions, P. P. Fu and L. S. von Tungeln for circular dichroism spectroscopy, S. N. Lekomtseva for the identification of T. viride, and J. V. Pothuluri for comments on the manuscript. We also thank Bayer Corp. for kindly providing us with the ciprofloxacin.

This work was supported in part by an appointment to the Postgraduate Research Program at the National Center for Toxicological Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration.


    FOOTNOTES
 
1 Present address: Department of Medicinal Chemistry, University of Mississippi, Oxford, MS 38677. Back

2 Corresponding author, Email: jsutherland{at}nctr.fda.gov Back

Accepted for publication June 28, 2001.


    LITERATURE CITED
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Chen Y, Rosazza JPN, Reese CP, Chang H-Y, Nowakowski MA, Kiplinger JP., 1997 Microbial models of soil metabolism: biotransformations of danofloxacin J Ind Microbiol Biotechnol 19:378-384[Medline]

Cooke RC, Rayner ADM., 1984 Ecology of saprotrophic fungi London: Longman Group. 415 p

Martens R, Wetzstein H-G, Zadrazil F, Capelari M, Hoffmann P, Schmeer N., 1996 Degradation of the fluoroquinolone enrofloxacin by wood-rotting fungi Appl Environ Microbiol 62:4206-4209[Abstract]

Mukhopadhyay T, Roy K, Sawant SN, Deshmukh SK, Ganguli BN, Fehlhaber HW., 1996 On an unstable antifungal metabolite from Trichoderma koningii: isolation and structure elucidation of a new cyclopentenone derivative (3-dimethylamino-5-hydroxy-5-vinyl-2-cyclopenten-1-one) J Antibiot 49:210-211[Medline]

Parshikov IA, Freeman JP, Lay JO, Beger RD, Williams AJ, Sutherland JB., 1999 Regioselective transformation of ciprofloxacin to N-acetylciprofloxacin by the fungus Mucor ramannianus FEMS Microbiol Lett 177:131-135[Medline]

Parshikov IA, Freeman JP, Lay JO, Beger RD, Williams AJ, Sutherland JB., 2000 Microbiological transformation of enrofloxacin by the fungus Mucor ramannianus Appl Environ Microbiol 66:2664-2667[Abstract/Free Full Text]

Parshikov IA, Freeman JP, Lay JO, Moody JD, Williams AJ, Beger RD, Sutherland JB., 2001a Metabolism of the veterinary fluoroquinolone sarafloxacin by the fungus Mucor ramannianus J Ind Microbiol Biotechnol 26:140-144[Medline]

Parshikov IA, Heinze TM, Moody JD, Freeman JP, Williams AJ, Sutherland JB., 2001b The fungus Pestalotiopsis guepini as a model for biotransformation of ciprofloxacin and norfloxacin Appl Microbiol Biotechnol 56:474–477

Pauliukonis LT, Musson DG, Bayne WF., 1984 Quantitation of norfloxacin, a new antibacterial agent in human plasma and urine by ion-pair reverse-phase chromatography J Pharm Sci 73:99-102[Medline]

Strunz GM, Ren W-Y, Stillwell MA, Valenta Z., 1977 Structure and synthesis of a new cyclopentenone derivative from Trichoderma album Can J Chem 55:2610-2612

Wetzstein H-G, Schmeer N, Karl W., 1997 Degradation of the fluoroquinolone enrofloxacin by the brown rot fungus Gloeophyllum striatum: identification of metabolites Appl Environ Microbiol 63:4272-4281[Abstract]

Wetzstein H-G, Stadler M, Tichy H-V, Dalhoff A, Karl W., 1999 Degradation of ciprofloxacin by basidiomycetes and identification of metabolites generated by the brown rot fungus Gloeophyllum striatum Appl Environ Microbiol 65:1556-1563[Abstract/Free Full Text]

Zeiler H-J, Petersen U, Gau W, Ploschke HJ., 1987 Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay Arzneim-Forsch/Drug Res 37:131-134





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parshikov, I. A.
Right arrow Articles by Sutherland, J. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Parshikov, I. A.
Right arrow Articles by Sutherland, J. B.
Agricola
Right arrow Articles by Parshikov, I. A.
Right arrow Articles by Sutherland, J. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS